EPE C for VE T E R A N S EPE C for VE T E R A N S Education in Palliative and End-of-life Care for Veterans is a collaborative effort between the Department.

Slides:



Advertisements
Similar presentations
Constipation and the Cancer Patient
Advertisements

Management Of Nausea and Vomiting in Palliative Care
Nausea & Vomiting ‘made easy’.
Copyright © 2013, 2010 by Saunders, an imprint of Elsevier Inc. Chapter 79 Laxatives.
EPECEPECEPECEPEC EPECEPECEPECEPEC Common Physical Symptoms Common Physical Symptoms Module 10 The Project to Educate Physicians on End-of-life Care.
The EPEC-O Curriculum is produced by the EPEC TM Project with major funding provided by NCI, with supplemental funding provided by the Lance Armstrong.
2 nd Cancer Pain Symposium Opiate Related Side Effects: Focus on Constipation Lydia Mis, PharmD, BCOP Clinical Oncology Pharmacist June 6, 2008 Duke University.
Prof. Hanan Hagar Pharmacology Department College of Medicine
Drugs acting on the Gastrointestinal Tract:- Gastrointestinal diseases is a common clinical problem in veterinary practice, and accurate diagnosis is essential.
1 Chapter 8 Drugs for Gastrointestinal Disorders.
Constipation and Diarrhea Elizabeth Whiteman M.D..
PTP 546 Module 12: Gastrointestinal Pharmacology Jayne Hansche Lobert, MS, RN, ACNS-BC, NP 1Lobert.
Constipation Definition *is adecrease in the frequency of fecal elimenation *hard / dry and somtime painfull stools *normal stool range from three time.
Bowel Symptoms 1: Nausea & Vomiting Dr Iain Lawrie.
Nausea and Vomiting James Hallenbeck, MD Director, Palliative Care Services, Palo Alto VAHCS, Stanford University.
To prevent and relieve suffering, and promote quality of life at every stage of life.
The EPEC-O Curriculum is produced by the EPEC TM Project with major funding provided by NCI, with supplemental funding provided by the Lance Armstrong.
Case Two. MALIGNANT BOWEL OBSTRUCTION Malignant bowel obstruction can occur at any level in the GI tract presenting symptom in 16% colorectal tumours.
EPECEPECEPECEPEC American Osteopathic Association AOA: Treating Our Family and Yours Osteopathic EPEC Osteopathic EPEC Education for Osteopathic Physicians.
Management of Nausea & Vomiting
Nausea and Vomiting in Palliative Care Elizabeth Whiteman M.D.
Mosby items and derived items © 2005, 2002 by Mosby, Inc. CHAPTER 51 Antiemetic and Antinausea Agents.
Assessment and Management of Constipation
Large Intestine Working knowledge of physiological changes during disease processes & the effects of these on nutrition care.
Drugs for Treating GI Disorders Chapter 11. GI Disorders  Peptic Ulcer and Acid Reflux Disorders  Laxatives and Cathartics  Antidiarrheals  Antiemetics.
The EPEC-O Curriculum is produced by the EPEC TM Project with major funding provided by NCI, with supplemental funding provided by the Lance Armstrong.
Raneen Omary. Contents Definition Pathogenesis Epidemiology Acute Radiation Enteritis Chronic Radiation Enteritis Risk Factors Diagnosis DD Medical Management.
Department of Surgery Ruijin Clinical Medical College Shanghai Jiao Tong University.
Evaluation and Treatment of Nausea and Vomiting
Drugs Acting on the Gastrointestinal Tract. 1.Emetics and Antiemetics.
JUST NAUSEA ? Symptom management. JUST NAUSEA ? OBJECTIVES Identify the effects of Nausea on daily life Identify those palliative patients at greatest.
Seminar in Palliative Care September 26 – October 02, 2010 Salzburg, Austria in Collaboration with.
The EPEC-O Curriculum is produced by the EPEC TM Project with major funding provided by NCI, with supplemental funding provided by the Lance Armstrong.
Management of Constipation in Adults Stephen Aglubat, MD May 2012.
Managing Symptoms in Palliative Care. Aims  To gain an awareness of the most common symptoms in patients with life limiting diseases and why these occur.
The Basics of Symptom Management: Understanding, Assessment and Principles Dr. Leah Steinberg.
End of Life Symptom Management Dec 3, 2014 Mudit Dabral Rosene Pirrello.
Gastrointestinal Pharmacology
GI on HADJ Payman Adibi,MD Professor, GI section, Dept. of Medicine, IUMS.
ADSORBENTS & LAXATIVE By Wiwik Kusumawati. OBJECTIVE At the end of this topic the students will be able to : At the end of this topic the students will.
EPECEPECEPECEPEC GI Symptoms Module 10a The Education in Palliative and End-of-life Care program at Northwestern University Feinberg School of Medicine,
Mosby items and derived items © 2007, 2005, 2002 by Mosby, Inc., an affiliate of Elsevier Inc. CHAPTER 53 Antiemetic and Antinausea Drugs.
Seminar in Palliative Care September 26 – October 02, 2010 Salzburg, Austria in Collaboration with.
Laxative and anti-diarrheal
Constipation: The Latest and Greatest Rosene Pirrello, RPh Solomon Liao, MD.
Mual Muntah Afifah Machlaurin>. Siapkan kertas Sebutkan titik yang bertanggung jawab terhadap respon mualmuntah ! 2. Sebutkan 4 mekanisme stimulasi.
Drugs Used to Treat Nausea and Vomiting Chapter 34 Mosby items and derived items © 2010, 2007, 2004 by Mosby, Inc., an affiliate of Elsevier Inc.
Patient presenting with symptoms of constipation Identify causeIdentify cause. Consider disease, drugs, pregnancy, immobility, psychological problems Confirm.
Laxatives and Antidiarrheals
Palliative Care: Non pain symptoms Elizabeth Whiteman, M.D.
Anatomy and Physiology & Pathophysiology
TM The EPEC-O Project Education in Palliative and End-of-life Care - Oncology The EPEC TM -O Curriculum is produced by the EPEC TM Project with major funding.
TM The EPEC-O Project Education in Palliative and End-of-life Care - Oncology The EPEC TM -O Curriculum is produced by the EPEC TM Project with major funding.
TM The EPEC-O Project Education in Palliative and End-of-life Care - Oncology The EPEC TM O Curriculum is produced by the EPEC TM Project with major funding.
TM The EPEC-O Project Education in Palliative and End-of-life Care - Oncology The EPEC TM -O Curriculum is produced by the EPEC TM Project with major funding.
Management Of Nausea And Vomiting In Palliative Care
TM The EPEC-O Project Education in Palliative and End-of-life Care - Oncology The EPEC TM -O Curriculum is produced by the EPEC TM Project with major funding.
Chapter 33 Therapy of Gastrointestinal Disorders: Peptic Ulcers, GERD, and Vomiting.
Jeopardy Final Jeopardy Antacids Antiemetics/ Emetics $100 $100 $100
NCLEX Pharmacology Quiz on Respiratory & Gastrointestinal Drugs
Focus on Irritable Bowel Syndrome (IBS)
Nausea, Vomiting & Constipation
Drugs Used to Treat Constipation and Diarrhea
Drugs for the treatment of irritable bowel syndrome (IBS)
Cholelithiasis Pathophysiology Pigment stones Cholesterol stones
Other Gastrointestinal Drugs
Nausea & Vomiting ‘made easy’.
Management of Constipation in Adults
Nausea & Vomiting in Cancer Patients
Presentation transcript:

EPE C for VE T E R A N S EPE C for VE T E R A N S Education in Palliative and End-of-life Care for Veterans is a collaborative effort between the Department of Veterans Affairs and EPEC ® Module 6a GI Symptoms

Objectives Discuss pathophysiology of common GI symptoms in palliative care Discuss assessment strategies Describe management strategies

Nausea/vomiting... Definition nausea is an unpleasant subjective sensation of being about to vomit vomiting is the reflex expulsion of gastric contents through the mouth

... Nausea/vomiting Impact very distressing: awareness of nausea inability to keep food or fluids down acid and bitter tastes unpleasant smells of vomitus

Pathophysiology … Nausea subjective sensation (easily learned) stimulation gastrointestinal lining, CTZ, vestibular apparatus, cerebral cortex Vomiting neuromuscular reflex

… Pathophysiology Cortex Vestibular apparatus GI tract Chemoreceptor Trigger Zone (CTZ) Neurotransmitters l Neurokinin l Serotonin l Dopamine l Acetylcholine l Histamine Vomiting center

Assessment When Acute versus chronic Intermittent or constant Associated with sights or smells Eating patterns Bowel patterns Medications

Chemotherapy- associated nausea/vomiting Acute < 24 hours chemoreceptor trigger zone serotonin release in the gut Delayed 24 hours (may be days) unclear mechanism

Chemotherapy emetogenicity Emetogenic Class Examples of MedicationsIncidence of acute vomiting ICapecitabine, RituximabMinimal (<10%) IIGemcitabine, PaclitaxelLow (10-30%) III Doxorubicin, Carboplatin Mild (30-60%) IVModerate (80-90%) VCisplatin, high dose cyclophophamide High (>90%)

Management Dopamine antagonists Antihistamines Anticholinergics Serotonin antagonists Neurokinin antagonists Prokinetic agents Antacids Cytoprotective agents Other medications

Medications … Dopamine antagonists Haloperidol Metoclopramide Prochlorperazine Histamine antagonists Diphenhydramine Meclizine Hydroxyzine

… Medications … Acetylcholine antagonists Scopolamine Serotonin antagonists Granisetron Ondansetron Neurokinin-1 antagonists Aprepitant

… Medications Prokinetic agents Metoclopramide Antacids H2 receptor antagonists Proton pump inhibitors Dexamethasone 6-20 mg PO daily Tetrahydrocannabinol mg PO tid Anti-anxiety agents

Summary

Constipation Definition straining hard stool sensation of incomplete evacuation fewer than 3 BM / week 12 weeks duration > 2 symptoms

Pathophysiology Medications opioids calcium-channel blockers anticholinergic Decreased motility Ileus Mechanical obstruction Metabolic abnormalities Spinal cord compression Dehydration Autonomic dysfunction Malignancy

Assessment Specifically ask about bowel function Establish what is normal for patient

Management General measures regular toileting gastrocolic reflex activity Specific therapies softenersosmotics stimulantslubricants large volume enemas

Stool softeners Sodium docusate Calcium docusate

Stimulant laxatives Prune juice Senna Bisacodyl

Osmotic agents Lactulose or sorbitol Milk of magnesia (other Mg salts) Magnesium citrate Polyethylene glycol

Lubricants/enemas Glycerin suppositories Phosphate enema Oil retention enema Tap water, 500–1,000 ml

Opioid-induced constipation... Occurs with all opioids Pharmacological tolerance develops slowly, or not at all Dietary interventions alone usually not sufficient Avoid bulk-forming agents in debilitated patients

... Opioid-induced constipation Combination stimulant / softeners are useful first-line medications casanthranol + docusate sodium senna + docusate sodium Prokinetic agents Opioid antagonists

Summary

Diarrhea Definition: stool that is looser than ‘normal’ and /or increased in frequency

Pathophysiology Secretory Osmotic Inflammatory Infectious

Assessment Medical history laxative use previous antibiotics last BM Physical examination Tests: C. diff. if recent hospitalizations or antibiotics

Specific types of diarrhea Medication-related diarrhea C. Difficile Diarrhea associated with enteral feeding dietary supplements Pancreatic insufficiency-associated diarrhea

Management Avoid gas-forming foods e.g. milk (lactose) Increase bulk Transient, mild diarrhea attapulgite bismuth salts

Management of persistent diarrhea Codeine Diphenoxylate/atropine Loperamide Cholestyramine Tincture of opium

Summary

Bowel obstruction Definition: mechanical or functional obstruction of the progress of food and fluids through the GI tract Prevalence range from 6% (ovarian cancer) to 48% (colorectal cancer) Prognosis – poor if inoperable

Pathophysiology Intraluminal mass Direct infiltration External compression Carcinomatosis Adhesions

Assessment Symptoms continuous distension pain 92% intestinal colic 72-76% nausea/vomiting % Abdominal radiograph dilated loops, air-fluid levels CT scan staging, treatment planning

Management Surgical evaluation Standard intravenous fluids nasogastric tube - intermittent suction Inoperable stent placement

Analgesics opioids Antiemetics haloperidol Steroids dexamethasone Pharmacological management

Antisecretory agents DrugDoseNotes Octreotide10 mcg/hr SQ/IV cont. infusion or 100 mcg SQ q 8 h Minimal adverse effects; titrate daily Scopolamine mcg/hr cont. infusion or 0.1 mg SQ q 6 h Anticholinergic effects may be dose-limiting; titrate daily Glycopyrrolate0.2 to 0.4 mg SQ q 2 to 4 h; titrate Anticholinergic effects possible

Anticholinergics Antispasmodic and antisecretory Scopolamine mcg/hr 0.1 mg sc q 6 h and titrate Glycopyrrolate mg sc q 2 to 4 h and titrate

Octreotide... Polypeptide analog of somatostatin serum half-life = 2 h Relieves symptoms of obstruction

... Octreotide Octreotide 10 mcg/hr continuous infusion Titrate to complete control of n/v If NG tube in place, clamp when volume diminishes to 100 cc and remove if no n/v Try convert to intermittent sc Continue until death

Summary

Ascites … Definition: accumulation of fluid in the abdomen 10% caused by malignancy Other etiologies: heart failure cirrhosis renal failure

... Ascites Prognosis: mean survival with malignant ascites < 4 months if chemo-responsive cancer (e.g. new dx ovarian ca) 6 months – 1 year

Pathophysiology... Normal physiology: intravascular pressure = extravascular pressure no extravascular fluid accumulation Ascites: fluid influx increases fluid outflow decreases fluid accumulates

... Pathophysiology Elevated hydrostatic pressure (e.g., congestive heart failure, cirrhosis) Decreased osmotic pressure (e.g., nephrotic syndrome, malnutrition) Fluid production > fluid resorption (infections, malignancy)

History & symptoms ankle swelling weight gain nausea discomfort Physical exam bulging flanks flank dullness shifting dullness fluid wave Assessment

Diagnostic imaging If physical exam is equivocal Detects small amounts of fluid, loculation ‘Ground Glass’ X-ray CT scan

Management Goal: to relieve the symptoms With little or no discomfort: don’t treat Before intervening, discuss prognosis, benefits, risks

Sodium and fluid balance Sodium and severe fluid restriction difficult for patients discuss benefits, burdens & other treatment options first

Diuretics Effective Well-tolerated Treatment goals: remove only enough fluid to manage the symptoms slow & gradual diuresis

Selecting a diuretic Spironolactone mg/day Amiloride mg/day Furosemide mg/day

Therapeutic paracentesis Indications: respiratory distress diuretic failure rapid symptomatic relief Safe In clinic or home

Summary

Mucositis Definition: mucosal barrier injury may affect the entire GI tract Impact oral erythema, ulceration, pain, infection diarrhea (if it affects entire GI tract) decreased oral intake Prevalence 40% of patients on chemotherapy 100% with stem cell transplants

Pathophysiology Direct injury Secondary infection Graft versus host disease (GVHD)

Assessment History pain and its effect on the patient eating and drinking Physical examination orthostatic blood pressure and pulse weight evaluate affected oral mucosa

Management... l Diminish mucosal delivery, e.g., oral cryotherapy l Modify epithelial proliferation, e.g., growth factors l Reduce infections, inflammatory complications l Reduce, inhibit pro-inflammatory cytokines

... Management Oral hygiene Diet (minimize contact with food) Local anesthetics Systemic analgesics

Summary